Cellzome and GSK research uncovers potential for new leukaemia drug
03 October 2011
Pial Ganguli
Please Login to read the full article.
03 October 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Acetylon raises $27M to test selective HDAC inhibitor in clinic for cancer
- Tensha banks $15M Series A to develop bromodomain inhibitor epigenetic drugs
- Takeda claims Aurora A kinase inhibitor lead as it takes alisertib into Phase III
- Reata takes AIM and scores $400 million in second Abbott hit
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
